汇宇制药-W
(688553)
| 流通市值：44.73亿 | | | 总市值：61.21亿 |
| 流通股本：3.10亿 | | | 总股本：4.24亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,226,834,716.33 | 2,033,607,564.78 | 1,967,379,986.81 | 1,782,479,208.18 |
| 应收票据及应收账款 | 57,032,323.59 | 56,148,303.14 | 40,266,519.19 | 55,946,183.81 |
| 应收账款 | 57,032,323.59 | 56,148,303.14 | 40,266,519.19 | 55,946,183.81 |
| 预付款项 | 26,787,628.18 | 24,866,619.97 | 24,562,265.05 | 19,580,787.08 |
| 其他应收款合计 | 6,485,111.18 | 6,592,857.27 | 7,484,893.84 | 7,630,480.72 |
| 存货 | 165,519,595.25 | 161,705,304.73 | 164,726,728.37 | 153,115,273.92 |
| 其他流动资产 | 85,316,392.3 | 85,044,996.95 | 76,279,379.26 | 62,352,123.04 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 3,059,569,944.91 | 2,829,559,824.92 | 2,971,856,903.97 | 2,870,156,288.2 |
| 非流动资产: | | | | |
| 长期股权投资 | 93,080,402.09 | 93,034,879.94 | 55,396,528.76 | 55,396,528.76 |
| 其他非流动金融资产 | 270,313,336.59 | 154,810,214.83 | 154,810,214.83 | 154,810,214.83 |
| 固定资产 | 647,897,922.53 | 625,148,028.83 | 633,965,428.15 | 637,532,266.24 |
| 在建工程 | 799,251,576.95 | 811,048,942.64 | 795,611,810.11 | 768,425,096.43 |
| 使用权资产 | 2,605,669.55 | 3,223,441.61 | 3,841,213.67 | 4,503,634.42 |
| 无形资产 | 60,506,722.17 | 61,066,076.91 | 61,625,431.65 | 62,092,458.06 |
| 开发支出 | 23,476,294.69 | 27,143,778.67 | 17,701,193.35 | 15,959,956.61 |
| 长期待摊费用 | 1,305,831.81 | 1,536,272.73 | 1,766,713.65 | 1,997,154.57 |
| 递延所得税资产 | 48,850,734.05 | 48,755,025.01 | 62,045,789.66 | 53,806,723.03 |
| 其他非流动资产 | 42,333,241.95 | 55,989,092.94 | 50,260,591.96 | 60,964,952.81 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,989,621,732.38 | 1,881,755,754.11 | 1,837,024,915.79 | 1,815,488,985.76 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 5,049,191,677.29 | 4,711,315,579.03 | 4,808,881,819.76 | 4,685,645,273.96 |
| 流动负债: | | | | |
| 短期借款 | 675,298,538.89 | 550,306,972.24 | 562,314,511.12 | 426,732,400.71 |
| 应付票据及应付账款 | 116,563,022.11 | 121,194,402.4 | 116,969,012.21 | 133,893,524.85 |
| 其中：应付票据 | - | - | 4,105,500 | 4,105,500 |
| 应付账款 | 116,563,022.11 | 121,194,402.4 | 112,863,512.21 | 129,788,024.85 |
| 合同负债 | 25,605,697.67 | 20,632,802.14 | 27,091,840.06 | 27,032,061.82 |
| 应付职工薪酬 | 34,098,684.74 | 28,679,725.98 | 24,821,909.31 | 40,407,873.31 |
| 应交税费 | 9,700,358.51 | 6,279,855.93 | 6,567,144.25 | 16,836,641.78 |
| 其他应付款合计 | 262,897,622.96 | 236,115,026.63 | 218,769,712.87 | 230,639,298.12 |
| 一年内到期的非流动负债 | 2,547,659.37 | 2,544,675.8 | 2,704,730.39 | 2,851,154.92 |
| 其他流动负债 | 671,866.88 | 795,503.43 | 982,537.94 | 931,914.6 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,127,383,451.13 | 966,548,964.55 | 960,221,398.15 | 879,324,870.11 |
| 非流动负债: | | | | |
| 租赁负债 | 11,220 | 737,609.6 | 1,151,455.81 | 2,048,310.02 |
| 递延收益 | 21,213,361.81 | 22,139,856.63 | 23,127,779.58 | 24,304,556.62 |
| 递延所得税负债 | 23,270,955.83 | 4,916,325.92 | 5,008,991.73 | 5,544,075.59 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 44,495,537.64 | 27,793,792.15 | 29,288,227.12 | 31,896,942.23 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,171,878,988.77 | 994,342,756.7 | 989,509,625.27 | 911,221,812.34 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 423,600,000 | 423,600,000 | 423,600,000 | 423,600,000 |
| 资本公积 | 2,485,318,082.86 | 2,485,318,082.86 | 2,485,318,082.86 | 2,485,318,082.86 |
| 减:库存股 | 30,020,576.71 | 30,020,576.71 | - | - |
| 其他综合收益 | -7,199,757.67 | -8,979,121.36 | -9,082,808.11 | -9,152,206.38 |
| 盈余公积 | 113,912,463.67 | 113,912,463.67 | 113,912,463.67 | 113,912,463.67 |
| 未分配利润 | 894,460,320.83 | 732,321,352.83 | 803,351,997.73 | 756,916,092.57 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,880,070,532.98 | 3,716,152,201.29 | 3,817,099,736.15 | 3,770,594,432.72 |
| 少数股东权益 | -2,757,844.46 | 820,621.04 | 2,272,458.34 | 3,829,028.9 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,877,312,688.52 | 3,716,972,822.33 | 3,819,372,194.49 | 3,774,423,461.62 |
| 负债和股东权益合计 | 5,049,191,677.29 | 4,711,315,579.03 | 4,808,881,819.76 | 4,685,645,273.96 |
| 公告日期 | 2024-10-26 | 2024-08-27 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |